IFOSFAMIDE BY CONTINUOUS INFUSION TO PREVENT ENCEPHALOPATHY

被引：73
作者：
CERNY, T
CASTIGLIONE, M
BRUNNER, K
KUPFER, A
MARTINELLI, G
LIND, M
机构：
[1] UNIV BERN,INST CLIN PHARMACOL,CH-3000 BERN,SWITZERLAND
[2] OSPED SAN GIOVANNI BELLINZONA,ONCOL SERV,BELLINZONA,SWITZERLAND
[3] NEWCASTLE GEN HOSP,DEPT CLIN ONCOL,NEWCASTLE TYNE NE4 6BE,TYNE & WEAR,ENGLAND
来源：
LANCET | 1990年 / 335卷 / 8682期
关键词：
D O I：
10.1016/0140-6736(90)90053-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：175 / 175
页数：1
相关论文
共 11 条
  • [1] RESPONSE TO IFOSFAMIDE AND MESNA - 124 PREVIOUSLY TREATED PATIENTS WITH METASTATIC OR UNRESECTABLE SARCOMA
    ANTMAN, KH
    RYAN, L
    ELIAS, A
    SHERMAN, D
    GRIER, HE
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (01) : 126 - 131
  • [2] A SIMPLE OUTPATIENT TREATMENT WITH ORAL IFOSFAMIDE AND ORAL ETOPOSIDE FOR PATIENTS WITH SMALL CELL LUNG-CANCER (SCLC)
    CERNY, T
    LIND, M
    THATCHER, N
    SWINDELL, R
    STOUT, R
    [J]. BRITISH JOURNAL OF CANCER, 1989, 60 (02) : 258 - 261
  • [3] CERNY T, 1987, CANCER CHEMOTH PHARM, V18, P261
  • [4] CERNY T, 1989, P ECCO LONDON, V5
  • [5] RESPONSE TO MESNA, DOXORUBICIN, IFOSFAMIDE, AND DACARBAZINE IN 108 PATIENTS WITH METASTATIC OR UNRESECTABLE SARCOMA AND NO PRIOR CHEMOTHERAPY
    ELIAS, A
    RYAN, L
    SULKES, A
    COLLINS, J
    AISNER, J
    ANTMAN, KH
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (09) : 1208 - 1216
  • [6] ELIAS A, 1989, ASCO P, V8, P264
  • [7] GOREN MP, 1986, LANCET, V2, P1219
  • [8] LIND MJ, 1989, CANCER RES, V49, P753
  • [9] Pratt CB, 1989, CANCER CHEMOTHER P S, V24, pS24
  • [10] WATKIN SW, 1989, EUR J CANCER CLIN ON, P1303
12